Thirteen years ago, a genetic screen in Caenorhabditis elegans, established to identify genes involved in developmental timing, resulted in the discovery of the first microRNA (miRNA), lin-4, which at the time was an unprecedented type of small regulatory RNA. After 7 years, the second RNA from this class, let-7, also emerged from a C. elegans genetic screen. The discovery of let-7 was particularly exciting because its phylogenetic conservation in metazoans implied that miRNAs represent a novel conserved regulatory mechanism and this immediately raised the question: how many miRNAs are out there? The discovery of let-7 coincided with an era when genetic and mechanistic studies started to unveil the mechanism of RNA interference, and the connection between the two pathways was soon made. The identification of the structural characteristics of miRNAs initiated the development of efficient cloning strategies that resulted in the isolation of dozens of miRNAs from diverse eukaryotic species. Meanwhile, many genome projects have been completed and the annotated genomes provided platforms to predict miRNAs based on their known features. This significantly extended the number of potential miRNA genes. Today, the miRBase database contains 4039 miRNA entries from 38 species. The large number of verified and predicted miRNAs immediately created a new challenge. What are the functions of miRNAs and what genes do they regulate? Genetic, cell biology and bioinformatics data suggest that miRNAs are key components of a wide range of biological processes, including pathways leading to cancer.
This issue of Oncogene reviews summarizes our recent knowledge about the connection between miRNAs and different aspects of tumorigenesis. The first two papers are dedicated to describing the mechanisms of miRNA production, miRNA processing and miRNA-mediated gene regulation. Zeng (2006) provides an overview of the transcription, nuclear processing and transport of miRNAs from the nucleus to the cytoplasm, where the final maturation steps occur, generating the singlestranded biologically active miRNAs. This review also devotes a section to discuss the differences between animal and plant miRNAs. The next review describes the mechanisms leading to formation of the RNA-induced silencing complex and explains how miRNA machines can regulate gene expression. In addition, it summarizes recent views about the global effects of miRNAs on the transcriptome and their influence on development (Engels and Hutvagner, 2006) .
Tumorigenesis is a multistep process during which cancer cells acquire characteristics, such as self-sufficiency in growth, evasion of apoptosis, insensitivity to growth inhibitory signals, limitless replicative potential, sustained angiogenesis and tissue invasion/metastasis. Dalmay and Edwards (2006) collected and combined bioinformatic predictions with available microarray data to hypothesize miRNAs function in several key cellular processes that are required for establishing these six characteristics. Jovanovic and Hengartner (2006) also review the roles of miRNAs in the regulation of apoptosis, a major barrier in cancer formation. The authors start their analysis in Drosophila, the model system that provided the first experimentally confirmed miRNA implicated in apoptosis. This is extended to mammals and then continued by discussing the function of virus-encoded miRNAs in the repression of apoptosis. In addition, miRNAs were very recently identified as a new class of genes with tumour suppressor and oncogenic functions. Kent and Mendell (2006) catalogue and discuss the role and significance of such miRNAs in tumour formation and inhibition. Furthermore, Jannot and Simard (2006) demonstrate that C. elegans is a valuable model system to investigate the function of miRNAs that regulate oncogenes. Cytogenetic abnormalities have been frequently observed in a wide range of cancers. Interestingly, more than half of the known miRNAs are situated on such chromosomal regions. Calin and Croce (2006) discuss how chromosomal rearrangements and epigenetic events influence miRNA expression and how this manifests in cellular processes that lead to malignancies. Up to 15% of human cancers are linked with viral infections and it is now well established that human viruses can also code miRNAs. Pfeffer and Voinnet (2006) review the interaction of viruses with the RNAi machineries and discuss the possible role of human virus-encoded miRNAs in oncogenesis. Finally, the early detection of cancer is key for the application of successful therapies. Cummins and Velculescu (2006) summarize the advances of miRNA expression profiling and discuss its recent and future potential in cancer diagnostics and prevention.
In spite of the first experimental verification of the connection between miRNAs and cancer being published only a year ago, research characterizing miRNA functions have already improved significantly our understanding about carcinogenesis and provided a promising tool for the detection and treatment of many forms of cancer.
